Irosustat Completed Phase 1 Trials for Prostate Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00790374BN83495 in Prostate Cancer